Literature DB >> 1396965

Evidence for oligoclonality of T cell receptor delta chain transcripts expressed in rheumatoid arthritis patients.

C Olive1, P A Gatenby, S W Serjeantson.   

Abstract

The inflamed synovium of rheumatoid arthritis (RA) patients contains gamma/delta T cells which express predominantly T cell receptor (TcR) variable (V) delta 1 and V delta 2 chains. Such T cells may contribute to the pathogenesis of RA. To assess the extent of clonality among these T cell populations we sequenced the junctional regions of rearranged TcR V delta 1-C delta and V delta 2-C delta chain cDNA, after using the polymerase chain reaction (PCR) to amplify TcR delta chain transcripts isolated from synovial membrane mononuclear cells (SMC) of five RA patients. The sequences of these delta chain transcripts were compared with those found in peripheral blood mononuclear cells (PBMC) of the same patients and in PBMC of four healthy controls. In contrast to control PBMC, V delta 1 chain cDNA derived from PBMC of three patients showed a strong bias towards usage of the same V-joining (J) combination and junctional region sequences, although the specific sequences were unique in each patient. However, oligoclonality of the V delta 1 chain was less marked in SMC of two of these patients and absent in SMC of the other patients. For V delta 2, oligoclonality was detected in PBMC of two patients. In SMC of a single patient, a dominant V delta 2 transcript was detected that utilized the J delta 2 segment, which was rarely expressed in the normal TcR repertoire. These results indicate in vivo clonal expansion of V delta 1- and V delta 2-expressing gamma/delta T cells in the peripheral blood of RA patients and a synovial T cell infiltrate which consists largely of polyclonally expanded gamma/delta T cells, but shows clonal dominance in some patients. Our data strongly support a role for V delta 1+ and V delta 2+ gamma/delta T cells in the pathogenesis of RA, and, although the nature of the antigen(s) recognized by these cells remains elusive, this report suggests the potential involvement of antigen(s) specific for the V region and V-J junction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1396965     DOI: 10.1002/eji.1830221018

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

Review 1.  Cellular immunity in osteoarthritis: novel concepts for an old disease.

Authors:  S N Liossis; G C Tsokos
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

Review 2.  The role of the T cell in autoimmune inflammation.

Authors:  Alla Skapenko; Jan Leipe; Peter E Lipsky; Hendrik Schulze-Koops
Journal:  Arthritis Res Ther       Date:  2005-03-16       Impact factor: 5.156

3.  Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients.

Authors:  C Olive; P A Gatenby; S W Serjeantson
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

4.  The gamma delta T cell repertoire in Graves' disease and multinodular goitre.

Authors:  R S McIntosh; N Tandon; A P Pickerill; R Davies; D Barnett; A P Weetman
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

5.  Gamma delta T cell receptor gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies.

Authors:  T P O'Hanlon; W A Messersmith; M C Dalakas; P H Plotz; F W Miller
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 6.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Peripheral selection of V delta 1+ cells with restricted T cell receptor delta gene junctional repertoire in the peripheral blood of healthy donors.

Authors:  K Beldjord; C Beldjord; E Macintyre; P Even; F Sigaux
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

Review 8.  The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases.

Authors:  Ilan Bank
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.